The prevalence and clinical implications of bronchiectasis in patients with sarcoidosis
A. Haywood (San Antonio, Texas, United States of America), J. Castaneda (San Antonio, Texas, United States of America), K. Proud (San Antonio, Texas, United States of America), M. Restrepo (San Antonio, Texas, United States of America), A. Diaz (Boston, Massachusetts, United States of America), D. Maselli (San Antonio, Texas, United States of America)
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Haywood (San Antonio, Texas, United States of America), J. Castaneda (San Antonio, Texas, United States of America), K. Proud (San Antonio, Texas, United States of America), M. Restrepo (San Antonio, Texas, United States of America), A. Diaz (Boston, Massachusetts, United States of America), D. Maselli (San Antonio, Texas, United States of America). The prevalence and clinical implications of bronchiectasis in patients with sarcoidosis. 1394
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Features of tuberculosis incidence and clinical forms for sarcoidosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 202s Year: 2004
Occurrence and impact of bronchiectasis in patients with COPD Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017
Prevalence and clinical relevance of comorbidities in IPF Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018
The features of patients with sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 436s Year: 2002
Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020
Effects of exacerbation risk on symptoms and clinical characteristics in patients with bronchiectasis Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation Year: 2012
Clinical relevance of bronchiectasis in COPD Source: Annual Congress 2010 - COPD: diagnosis Year: 2010
Aetiological testing in patients with bronchiectasis Source: International Congress 2014 – PG08 The management of non-CF bronchiectasis: from childhood to adulthood Year: 2014
The prognostic role of the bronchiectasis in patients with COPD Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017
Pulmonary aspergilloma: epidemiology and clinical features of Iranian patients Source: Eur Respir J 2002; 20: Suppl. 38, 352s Year: 2002
Prevalence of ocular sarcoidosis in patients with intra thoracic sarcoidosis Source: International Congress 2016 – The best clinical approach to lung diseases Year: 2016
Clinical features of COPD in patients with chronic pulmonary aspergillosis Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009
The comparison of sarcoidosis patients with benign and recurrent clinical course of the disease Source: Eur Respir J 2005; 26: Suppl. 49, 331s Year: 2005
Relationship between clinical symptoms and severity of alveolitis in patients with new-onset sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 468s Year: 2002
Impact of comorbidities and etiology of bronchiectasis on outcomes in hospitalised patients with bronchiectasis Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015
Radiological features of NTM pulmonary disease in patients with bronchiectasis Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis Year: 2020
Incidence, clinical manifestations and prognosis of cardiac sarcoidosis in patients with pulmonary sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013
Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients Source: Breathe, 16 (1) 190321; 10.1183/20734735.0321-2019 Year: 2020
Ocular manifestations in unselected group of sarcoid patients hospitalised in the national tuberculosis and lung diseases research institute Source: Eur Respir J 2002; 20: Suppl. 38, 435s Year: 2002
Relationship between clinical and radiological signs of bronchiectasis in COPD patients: Results from COSYCONET Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020